FORX THERAPEUTICS
FoRx Therapeutics is a recently incorporated privately-held company aiming to develop first-in-class compounds for cancer treatment. FoRx focuses on drugging key molecular targets involved in DNA replication stress, as a new approach towards the development of targeted anticancer drugs.
FORX THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2019-10-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.forxtherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Core Biogenesis
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
Cultiply
Cultiply is a biotechnology company focused on the innovation and optimization of industrial fermentation processes.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Current Employees Featured
Founder
Investors List
Novartis Venture Fund
Novartis Venture Fund investment in Seed Round - FoRx Therapeutics
Omega Funds
Omega Funds investment in Seed Round - FoRx Therapeutics
Life Sciences Partners
Life Sciences Partners investment in Seed Round - FoRx Therapeutics
Pfizer
Pfizer investment in Seed Round - FoRx Therapeutics
M Ventures
M Ventures investment in Seed Round - FoRx Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Seed Round - FoRx Therapeutics
Official Site Inspections
http://www.forxtherapeutics.com Semrush global rank: 4.45 M Semrush visits lastest month: 2.46 K
- Host name: dedi1157.your-server.de
- IP address: 85.10.214.227
- Location: Nuremberg Germany
- Latitude: 49.4475
- Longitude: 11.0683
- Timezone: Europe/Berlin
- Postal: 90409

More informations about "FoRx Therapeutics"
Board of Directors - FoRx Therapeutics
Previously, Dr Kauffman served as the co-founder and CEO of Karyopharm, where he guided the Companyโs transition from a start-up biotechnology company to a commercial stage โฆSee details»
FoRx Therapeutics - Crunchbase Company Profile
FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.See details»
Management Team - FoRx Therapeutics
Tarig Bashir PhD โ Chief Executive Officer (CEO) Tarig Bashir, PhD, joined FoRx Therapeutics as CEO in April 2021. He is a Pharma and Biotech Executive with over 15 years of โฆSee details»
FoRx Therapeutics - LinkedIn
FoRx Therapeutics is a recently incorporated privately-held company based in Basel, Switzerland. It is backed by a syndicate of investors that include the Novartis Venture Fund, Pfizer โฆSee details»
FoRx Therapeutics | Novartis Venture Fund
Learn about FoRx Therapeutics, a Novartis Venture Fund portfolio company developing novel anti-cancer therapies.See details»
FoRx Therapeutics Company Profile - Office Locations ... - Craft
FoRx Therapeutics has 5 employees at their 1 location and $10.84 m in total funding,. See insights on FoRx Therapeutics including office locations, competitors, revenue, financials, โฆSee details»
FoRx Therapeutics AG โ Swiss Biotech
FoRx Therapeutics is a recently incorporated privately-held company based in Basel, Switzerland. FoRx Therapeutics focuses on drugging key molecular targets involved in the DNA Replication Stress, as a new approach in the โฆSee details»
FoRx Therapeutics - VentureRadar
"FoRx Therapeutics is a privately-held company dedicated to developing first-in-class compounds for cancer treatment. The company focuses on targeting key molecular mechanisms involved โฆSee details»
FoRx Therapeutics 2025 Company Profile: Valuation, โฆ
Information on valuation, funding, cap tables, investors, and executives for FoRx Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
FoRx Therapeutics Company Information - Funding, Investors, and โฆ
FoRx Therapeutics FoRx Therapeutics is a Basel-based biotechnology company developing a drug discovery platform for cancer drugs.See details»
FoRx Therapeutics AG - life-sciences-europe.com
FoRx Therapeutics, was founded in the fall of 2019, is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways activated โฆSee details»
FoRx Therapeutics Company Overview, Contact Details
Apr 22, 2020 Learn more about FoRx Therapeutics's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
FoRx Therapeutics - VentureRadar
FoRx Therapeutics is a recently incorporated privately-held company aiming to develop first-in-class compounds for cancer treatment. FoRx focuses on drugging key molecular targets โฆSee details»
FoRx Therapeutics - Overview, News & Similar companies
View FoRx Therapeutics (www.forxtherapeutics.com) location in Basel-City, Switzerland , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
Media Release FoRx Therapeutics appoints Chief Medical Officer โฆ
FoRx Therapeutics appoints Chief Medical Officer and provides an update on its lead development candidate Basel, Switzerland โ 26 February 2025. FoRx Therapeutics AG, a โฆSee details»
FoRx Therapeutics AG - startup.ch
FoRx Therapeutics AG: FoRx Therapeutics is a recently incorporated privately-held company based in Basel, Switzerland. It is backed by a syndicate of investors that include the Novartis โฆSee details»
FoRx Therapeutics AG | BIO-Europe - informaconnect.com
FoRx Therapeutics is an incorporated privately held drug discovery company based in Basel, Switzerland. The company is active in oncology and focuses on drugging key molecular โฆSee details»
Pipeline | FoRx Therapeutics
FORX-002: This unique and novel target was identified in a screen for sensitizers to DNA replication stress. FORX-002 is a first-in-class program that is currently in Lead Identification. โฆSee details»
FoRx Therapeutics AG at the Swiss Biotech Day
FoRx Therapeutics focuses on the discovery and development of small molecule inhibitors against key proteins involved in the response to oncogene-induced DNA replication stress, โฆSee details»